For Cancer Patients, Newest Treatments Force the Ultimate Decision, with No Room for Error

October 7, 2016

(STAT News) – Immunotherapy, which harnesses the body’s immune system to attack tumors, brings with it the hope of significant remission, if not a cure, for some patients. But clinical trials often exclude those who have already had similar treatments, in part because researchers are seeking clear indications of a particular drug’s effectiveness. For patients, that means the stakes on a single decision couldn’t be higher. And many have little data on the drugs to guide them.

Recommended Reading